Search Results - "KRAUSE, Steffen F"

Magnetic Resonance Image-Guided Biopsies with a High Detection Rate of Prostate Cancer by Engehausen, Dirk G., Engelhard, Karl, Schwab, Siegfried A., Uder, Michael, Wach, Sven, Wullich, Bernd, Krause, F. Steffen

“…Aim. To explore the potential of transrectal magnetic resonance image- (MRI-) guided biopsies of the prostate in a patient cohort with prior negative…”
Get full text

Survivin Expression as a Predictive Marker for Local Control in Patients With High-Risk T1 Bladder Cancer Treated With Transurethral Resection and Radiochemotherapy by Weiss, Christian, M.D, von Römer, Felix, Capalbo, Gianni, Ph.D, Ott, Oliver J., M.D, Wittlinger, Michael, M.D, Krause, Steffen F., M.D, Sauer, Rolf, M.D, Rödel, Claus, M.D, Rödel, Franz, Ph.D

“…Purpose The objectives of this study were to investigate the expression of survivin in tumor samples from patients with high-risk T1 bladder cancer and to…”
Get full text

Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? by STEFFEN KRAUSE, F, RAUCH, Anita, SCHROTT, Karl M, ENGEHAUSEN, Dirk G

“…Non-invasive methods for detecting genetic alterations of bladder cancer are increasingly becoming the focus of attention as diagnostic tools. The fluorescence…”
Get full text

MRI Spectroscopy in Screening of Prostate Cancer by GOEB, Katja, ENGEHAUSEN, Dirk G, KRAUSE, F. Steffen, HOLLENBACH, Hans-Peter, NIEDOBITEK, Gerald, BUETTNER, Maike, FRANGOU, Phroso, ENGELHARD, Karl

“…Background: The purpose of this study was to evaluate the suitability of MR Spectroscopy in screening for prostate cancer in comparison to T2-weighted MR…”
Get full text

How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience by Sikic, Danijel, Wach, Sven, Taubert, Helge, Richterstetter, Mario, Kunath, Frank, Lieb, Verena, Krause, F Steffen, Merten, Ricarda, Ott, Oliver, Fietkau, Rainer, Wullich, Bernd, Keck, Bastian

“…With increasing life expectancy, curative treatment of octogenarians with urothelial carcinoma of the bladder (UCB) becomes more important. The treatment…”
Get more information

Efficacy Management of Urolithiasis: Flexible Ureteroscopy versus Extracorporeal Shockwave Lithotripsy by Tauber, Volkmar, Wohlmuth, Martin, Hochmuth, Andreas, Schimetta, Wolfgang, Schimetta, Wofgang, Krause, F Steffen

“…To evaluate the efficacy of flexible ureterscopy (fURS) and extracorporal shockwave lithotripsy (SWL) in the treatment of urolithiasis, complemented by a…”
Get more information

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia by Wittlinger, Michael, Rödel, Claus M, Weiss, Christian, Krause, Steffen F, Kühn, Reinhard, Fietkau, Rainer, Sauer, Rolf, Ott, Oliver J

“…Abstract Background and purpose To assess the safety and effectiveness of treating high-risk T1 and T2 bladder cancer with transurethral resection (TUR-BT)…”
Get full text

Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older by Berger, Ingrid, Wehrberger, Clemens, Ponholzer, Anton, Wolfgang, Martina, Martini, Thomas, Breinl, Eckart, Dunzinger, Michael, Hofbauer, Johann, Höltl, Wolfgang, Jeschke, Klaus, Krause, Steffen F, Kugler, Walter, Rauchenwald, Michael, Pauer, Walter, Pycha, Armin, Madersbacher, Stephan

“…A potential strategy to decrease the high complication rate of radical cystectomy (RC) in the elderly is to avoid the use of bowel for urinary diversion. The…”
Get more information

Heterogeneity in Prostate Cancer: Prostate Specific Antigen (PSA) and DNA Cytophotometry by KRAUSE, F. Steffen, FEIL, Gerhard, BICHLER, Karl-Horst, SCHROTT, Karl M, AKCETIN, Ziya Y, ENGEHAUSEN, Dirk G

“…Background: The heterogeneity in prostate cancer is the reason for the difficult diagnosis and prognosis of this tumor. In this study, we looked for a…”
Get full text

Polymorphisms in the Human Progesterone Receptor (PGR) Gene of Two Human Prostate Adenocarcinoma Cell Lines by ENGEHAUSEN, Dirk G, ENDELE, Sabine, KRAUSE, Steffen F, RITH, Torsten, SCHROTT, Karl M, AKCETIN, Ziya

“…Background: The incidence and mortality rate of prostate cancer has been steadily increasing in most countries worldwide. A potential implication of the…”
Get full text

Polymorphisms of Human Androgen Receptor (hAR) Gene in Prostate Cancer Cell Lines PC-EW and PC-OR by ENGEHAUSEN, Dirk G, KRAUSE, F. Steffen, FLEISCHMANN, Johann, AKCETIN, Ziya, SCHROTT, Karl M, ENDELE, Sabine

“…Background: Prostate cancer is the leading tumor of the male in Western societies. Genetic alterations of the androgen receptor gene are known in the advanced…”
Get full text

Bladder cancer--the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register ClinicalTrials.gov by Kunath, Frank, Krause, Steffen F, Wullich, Bernd, Goebell, Peter J, Engehausen, Dirk G, Burger, Maximilian, Meerpohl, Joerg J, Keck, Bastian

“…Uro-oncological neoplasms have both a high incidence and mortality rate and are therefore a major public health problem. The aim of this study was to evaluate…”
Get full text

Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool? by Krause, F Steffen, Feil, Gerhard, Bichler, Karl-H, Schrott, Karl M, Akcetin, Ziya Y

“…The employment of DNA flow or image cytometry for oncological diagnostic procedures is favored because of its high correlation to tumor biological behavior…”
Get more information

Treatment Options for High-Risk T1 Bladder Cancer: Status Quo and Future Perspectives of Radiochemotherapy by Weiss, Christian, Ott, Oliver J., Wittlinger, Michael, Krause, Steffen F., Fietkau, Rainer, Sauer, Rolf, Rödel, Claus

“…Purpose: To review the standards and new developments in diagnosis and management of high-risk T1 bladder cancer with emphasis on the role of radiotherapy (RT)…”
Get full text

Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer by Krause, F S, Feil, G, Bichler, K H

“…Bladder cancer is clinically characterized by a high recurrence rate for superficial tumours up to 70% and by the invasiveness of advanced bladder cancer. To…”
Get more information

Molecular genetic methods in the diagnosis of invasive bladder cancer by Krause, F S, Feil, G, Zumbrägel, A, Bichler, K H

“…Development and progression of tumours is generally driven by an accumulation of genetic alterations. In this study we correlated chromosome 17 aneuploidy to…”
Get more information

Detection of HER-2/neu CEP 17 mutations at invasive bladder cancer by Feil, Gerhard, Krause, F Steffen, Zumbraegel, Andreas, Bichler, Karl H

Get more information

Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence? by Feil, Gerhard, Krause, F Steffen, Zumbraegel, Andreas, Wechsel, Hans W, Bichler, Karl H

Get more information